Recent Progress in Therapeutic Strategies for Ischemic Stroke

Toru Yamashita1, Koji Abe

  • 1Department of Neurology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan.

Cell Transplantation
|January 21, 2016
PubMed

Insights

This study explored neuroprotection and stem cell therapy for stroke treatment. Combining glial cell line-derived neurotrophic factor (GDNF) and induced pluripotent stem cells (iPSCs) shows promise for stroke recovery, pending control of iPSC-related tumor formation.

Area of Science:

  • Neuroscience
  • Regenerative Medicine
  • Stroke Research

Background:

  • Stroke treatment strategies include acute neuroprotection and chronic stem cell therapy.
  • Previous research identified a neuroprotection window (12-48h) post-ischemia.
  • Investigated temporal and spatial expression of key proteins (c-fos, HIF-1α, HSP70, annexin V) after transient middle cerebral artery occlusion in rats.

Purpose of the Study:

  • To evaluate the neuroprotective effects of glial cell line-derived neurotrophic factor (GDNF) and hepatocyte growth factor (HGF) in ischemic stroke models.
  • To assess the potential of induced pluripotent stem cells (iPSCs) for neural regeneration after stroke.
  • To explore combined therapeutic strategies for stroke treatment.

Main Methods:

  • Administered GDNF via Sendai viral vector gene transfer into post-ischemic rat brains.
  • Administered GDNF and HGF proteins into post-ischemic rat brains.
  • Transplanted undifferentiated iPSCs into the ischemic striatum and cortex of rats.

Main Results:

  • Sendai virus-mediated GDNF gene transfer demonstrated significant neuroprotection.
  • GDNF and HGF reduced infarct size, apoptosis (TUNEL-positive cells), and autophagy (LC3-positive cells).
  • iPSC transplantation yielded doublecortin-positive neuroblasts but also resulted in teratoma formation.

Conclusions:

  • GDNF and HGF exhibit both anti-apoptotic and anti-autophagic effects, reducing stroke-induced damage.
  • iPSCs hold potential for neural cell replacement after ischemic brain injury, provided tumorigenesis is managed.
  • Combining neurotrophic factor therapy with stem cell transplantation may offer a more effective stroke treatment approach.

Related Concept Videos

Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
440
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
398
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
547
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
460
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
578
Atherosclerosis IV: Nursing Management01:23

Atherosclerosis IV: Nursing Management

Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
563